SLNO – soleno therapeutics, inc. (US:NASDAQ)

News

Soleno Therapeutics (NASDAQ:SLNO) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround [Yahoo! Finance]
Soleno Therapeutics to Participate in Upcoming Conferences [Yahoo! Finance]
Soleno Therapeutics to Participate in Upcoming Conferences
Soleno Therapeutics (NASDAQ:SLNO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com